Medical Devices

Image

Europe Long Read Sequencing Market – Industry Trends and Forecast to 2030

  • Medical Devices
  • Upcoming Report
  • Dec 2022
  • Europe
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Europe Long Read Sequencing Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 515.64 Million
Diagram Market Size (Forecast Year) USD 2514.06 Million
Diagram CAGR %

Europe Long Read Sequencing Market, By Technology (Single-Molecule Real-Time Sequencing, Nanopore Sequencing, Synthetic Long Read Sequencing, and Others), Product (Instruments, Consumables, and Services), Application (Whole Genome Sequencing, Epigenetics, RNA Sequencing, Complex Population, Targeted Sequencing, Identification and fine mapping of structural variation, Tandem Repeat Sequencing, Pseudogene discrimination, Resolving allele phasing, Reproductive genomics, Cancer, Viral and Microbial Sequencing and Others), Workflow (Pre-Sequencing, Sequencing, and Data Analysis), End-user (Academic and Research Institutes, Clinical Laboratories, Hospitals, Pharma and Biotech Entities, and Others) – Industry Trends and Forecast to 2030.

Europe Long Read Sequencing Market

Europe Long Read Sequencing Market Analysis and Size

According to the World Health Organization (WHO), around 72,000 newborn babies are affected by sickle cell anaemia, a severe genetic disorder. Hemophilia, a genetic bleeding disorder, has also affected over 6000 people in the United Kingdom. Furthermore, alpha and beta-thalassemia are the most common inherited single gene affected genetic disorders in the world, accounting for the majority of cases. The burden of this disorder is high, such as in Iran, where the WHO estimates that approximately 8,000 pregnancies are at risk of the disease each year. Additionally, other genetic diseases such as colour blindness, Down syndrome, cystic fibrosis, and frequent incidences of DNA, RNA, and protein synthesis disorders are expected to drive the growth of the long-read sequencing market as demand for early diagnosis grows.

Data Bridge Market Research analyses that the long read sequencing market, which was USD 515.64 million in 2022, would be up to USD 2514.06 million by 2030 and is expected to undergo a CAGR of 21.9% during the forecast period 2023-2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework

Europe Long Read Sequencing Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015- 2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Technology (Single-Molecule Real-Time Sequencing, Nanopore Sequencing, Synthetic Long Read Sequencing and Others), Product (Instruments, Consumables and Services), Application (Whole Genome Sequencing, Epigenetics, RNA Sequencing, Complex Population, Targeted Sequencing, and Others), Workflow (Pre-Sequencing, Sequencing, and Data Analysis), End-user (Academic and Research Institutes, Clinical Laboratories, Hospitals, Pharma and Biotech Entities, and Others)

Countries Covered

Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe

Market Players Covered

Illumina, Inc. (U.S.), MicrobesNG (U..S), Roche Sequencing (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), PacBio (U.S.), Oxford Nanopore Technologies plc (U.K.), Quantapore, Inc. (U.S.), FG Technologies(Switzerland), BaseClearB.V (Netherlands)  INSTITUTE OF INTEGRATIVE CELL BIOLOGY AND PHYSIOLOGY ( France), The Garvan Institute (Australia), Génomique (France), Takara Holdings Inc. (Japan), Genexa AG (Switzerland)

Market Opportunities

  • Rising utilization of sequence analysis methodologies

Market Definition

Long-read sequencing, also known as third-generation sequencing, is a technique for large-scale data analysis. This is a technology in which DNA particles are sequenced in real-time, and long reads are produced as a result of this straight sequencing. Frequently, these sequencing reactions are approved without the use of PCR amplification. Long-read sequencing techniques include single molecule real-time (SMRT) and nanopore sequencing.

Europe Long Read Sequencing Market Dynamics

Drivers

  • The surge in incidences of genetic disorders

The growing number of entities affected by genetic disorders will contribute to market growth in the coming years. According to the Centers for Disease Control and Prevention, there are approximately 100,000 sickle cell disease patients in the United States. The advancement of patients will pique the interest of many key companies, which is expected to propel the market's growth.

  • Rising use of long-read sequencing

Long-read sequencing has numerous advantages over short or second-generation sequencing techniques, which is fuelling market growth even further. For instance, long reads generated by single-molecule real-time sequencing (SMRT) provide a comprehensive overview of the entire genome and are used to detect various genetic and structural variants. Long-read sequencing, researchers estimated in 2015, could be used to assemble dozens of bacterial and viral genomes. Aside from that, increased R&D investments and rising awareness of long read sequencing drive market growth.

Opportunities

  • Rising utilization of sequence analysis methodologies

One of the key factors driving market growth is the growing acceptance of modern medical diagnostic approaches. LRS technology's growing popularity is also due to its portability and real-time speed. It is also used to generate an accurate reference map of the centromeres on the chromosomes. In addition, several biotech companies are working on novel technologies that combine a new library prep method with genome analysis tools. Several studies have demonstrated that LRS technology is critical for identifying novel pathogenic mutations in human diseases with unknown genetic causes. This provides numerous opportunities for researchers to use the technology in whole-genome sequencing (WGS), allowing medical genetics to progress.

Restraints/Challenges

  • Higher cost per base relative to short-read sequencing

Long-read sequencing market is facing trials due to the lack of highly cutting-edge genomic testing centers, expensive installation processes, and the absence of experts specific with progressive diagnostic abilities.

This long read sequencing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the long read sequencing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

  • In 2019, Oxford Nanopore created Flongle to quickly analyse short DNA/RNA sequences. Flongle is a GridION X5 desktop and MinION portable sequencing adaptor. Small Flange cells with up to 1.8 Gb of sequence data capacity and headroom for up to 3 Gb. This merchandise promotion will help the company's product portfolio to be more consolidated.
  • In 2020, Promega Corporation launched the Wizard HMW DNA Extraction Kit for scientists working with large genomic DNA fragments. Using this kit, researchers can obtain DNA fragments that will improve performance in long read sequencing applications in 90 minutes. As a result, the company's product portfolio has become more appealing, appealing, and advanced.

Europe Long Read Sequencing Market Scope

The long read sequencing market is segmented on the basis of technology, product, workflow, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Technology

Product

  • Consumables
  • Instruments

Type

  • System
  • Software
  • Services

Workflow

  • Sequencing
  • Data Analysis
  • Pre-Sequencing

Application

  • Whole Genome Sequencing
  • Epigenetics
  • RNA Sequencing
  • Complex Population
  • Tandem Repeat Sequencing
  • Identification and fine mapping of structural variation
  • Viral and Microbial Sequencing
  • Reproductive genomics
  • Pseudogene discrimination
  • Others

End User

  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Industry
  • Others

Long Read Sequencing Market Regional Analysis/Insights

The long read sequencing market is analyzed and market size insights and trends are provided by country, technology, product, workflow, application and end-user as referenced above.

The countries covered in the long read sequencing market report are Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe.

Germany is dominating the long read sequencing market due to the large number of companies and the increasing adoption of next generation sequencing for clinical diagnostics.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Long Read Sequencing Market Share Analysis

The long read sequencing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to long read sequencing market.

Some of the major players operating in the long read sequencing market are:

  • Illumina, Inc. (U.S.)
  • MicrobesNG (U.S.)
  • Roche Sequencing (U.S.)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • PacBio (U.S.)
  • Oxford Nanopore Technologies plc (U.K.)
  • Quantapore, Inc. (U.S.)
  • FG Technologies (Switzerland)
  • BaseClear B.V (Netherlands)
  • INSTITUTE OF INTEGRATIVE CELL BIOLOGY AND PHYSIOLOGY (France)
  • The Garvan Institute (Australia)
  • France Génomique (France)
  • Takara Holdings Inc. (Japan)
  • Genexa AG (Switzerland)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Europe Long Read Sequencing Market is projected to grow at a CAGR of 21.9% during the forecast period by 2030.
The future market value of the Europe Long Read Sequencing Market is expected to reach USD 2514.06 million by 2030.
The major players in the Europe Long Read Sequencing Market are Illumina, Inc. (U.S.), MicrobesNG (U.S), Roche Sequencing (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), PacBio (U.S.), Oxford Nanopore Technologies plc (U.K.), Quantapore, Inc. (U.S.), etc.
The countries covered in the Europe Long Read Sequencing Market are Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe.
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials